首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

1890980

急性胰臟炎市場按病因、治療類型、給藥途徑、病患小組、最終用戶、分銷管道和地區分類

Acute Pancreatitis Market, By Etiology, By Treatment Type, By Route of Administration, By Patient Group, By End User, By Distribution Channel, By Geography

出版日期: 2025年11月10日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年急性胰臟炎市場規模預計為 36.2 億美元，預計到 2032 年將達到 54.1 億美元，2025 年至 2032 年的複合年成長率為 5.9%。

報告內容		報告詳情
基準年：	2024	2025年市場規模：	36.2億美元
歷史數據時期：	2020-2024	預測期：	2025-2032
預測期間（2025-2032年）：	5.90%	2032 年的預測值：	54.1億美元

急性胰臟炎是嚴重的胰臟發炎性疾病，其特徵是劇烈腹痛、胰酶水平升高，並可能出現危及生命的併發症，需要立即進行醫療干預。全球急性胰臟炎市場涵蓋了一系列全面的診斷工具、治療性介入和支持性護理解決方案，旨在應對這種複雜的醫療緊急情況。

該市場涵蓋先進的成像技術，例如電腦斷層掃描和MRI系統；酵素檢測實驗室設備；包括止痛藥和酵素替代療法在內的藥物治療；以及用於內視鏡介入的專用醫療設備。膽結石盛行率的上升、飲酒以及生活方式相關的危險因素，是導致全球急性胰臟炎發生率增加的重要因素。全球醫療系統正面臨著與該疾病相關的急診就診和住院人數激增的局面，這極大地推動了對有效治療方案的需求。

市場動態

全球急性胰臟炎市場主要受多種強勁因素驅動，這些因素共同支撐著其穩健的成長動能。膽結石約佔急性胰臟炎病例的40-50%，尤其是在已開發國家，飲食習慣和久坐的生活方式是導致膽囊併發症的重要因素。全球酒精消費量的成長，尤其是在新興經濟體，是酒精性胰臟炎病例的重要來源，從而持續推高了對治療方案的需求。高解析度CT掃描儀、磁振造影造影（MRCP）和內視鏡超音波系統等診斷影像技術的進步，正在革新早期檢測和嚴重程度評估的能力。

然而，目前仍有許多限制，例如先進診斷設備和專業治療的高成本，這限制了資源匱乏的醫療環境中的可近性。急性胰臟炎的治療十分複雜，需要胃腸科醫師、外科醫師和加護治療專家等多學科協作，因此制定標準化治療通訊協定面臨挑戰。此外，目前缺乏針對胰臟炎的特效藥物，治療主要著重於支持性護理，嚴重限制了市場發展。然而，全球人口老化加劇，老年人更容易罹患胰臟疾病，這為市場帶來了巨大的機會。開發中國家醫療支出不斷成長，醫療保險覆蓋範圍不斷擴大，加之市場環境有利，共同創造了有利條件。人工智慧在診斷影像領域的應用以及個人化醫療的發展，為急性胰臟炎治療的市場擴張和創新提供了廣闊前景。

本次調查的主要特點

本報告對全球急性胰臟炎市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和復合年成長率（%）。
它還重點介紹了各個細分市場的潛在商機，並為該市場說明了一個有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業。
本報告根據以下參數對全球急性胰臟炎市場的主要企業進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
這份全球急性胰臟炎市場報告的目標受眾是該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過全球急性胰臟炎市場分析中使用的各種策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第11章競爭格局

Boston Scientific
AbbVie
Cook Medical
Medtronic
Olympus Corporation
Fujifilm Healthcare
Pentax Medical
ConMed
Teleflex
Baxter International
Braun Melsungen AG
Fresenius Kabi
Abbott Laboratories
ICU Medical
ERBE Elektromedizin

第12章分析師建議

機會
一致的機會地圖

第13章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI8894

Acute Pancreatitis Market is estimated to be valued at USD 3.62 Bn in 2025 and is expected to reach USD 5.41 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.62 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.90%	2032 Value Projection:	USD 5.41 Bn

Acute pancreatitis represents a critical inflammatory condition of the pancreas that demands immediate medical intervention, characterized by severe abdominal pain, elevated pancreatic enzymes, and potential life-threatening complications. The global acute pancreatitis market encompasses a comprehensive range of diagnostic tools, therapeutic interventions, and supportive care solutions designed to address this complex medical emergency.

This market includes advanced imaging technologies such as CT scans and MRI systems, laboratory diagnostic equipment for enzyme detection, pharmaceutical treatments including pain management medications and enzyme supplements, as well as specialized medical devices for endoscopic interventions. The rising prevalence of gallstone disease, alcohol consumption, and lifestyle-related risk factors has significantly contributed to the increasing incidence of acute pancreatitis worldwide. Healthcare systems globally are witnessing a surge in emergency department visits and hospitalizations related to this condition, driving substantial demand for effective treatment modalities.

Market Dynamics

The global acute pancreatitis market is primarily driven by several compelling factors that collectively fuel its robust growth trajectory. The increasing prevalence of gallstone disease, which accounts for approximately 40-50% of acute pancreatitis cases, serves as a major market driver, particularly in developed countries where dietary habits and sedentary lifestyles contribute to gallbladder complications. Rising alcohol consumption patterns globally, especially in emerging economies, significantly contribute to alcohol-induced pancreatitis cases, creating sustained demand for treatment solutions. Technological advancements in diagnostic imaging, including high-resolution CT scanners, magnetic resonance cholangiopancreatography (MRCP), and endoscopic ultrasound systems, are revolutionizing early detection and severity assessment capabilities.

However, the market faces notable restraints including the high cost of advanced diagnostic equipment and specialized treatments, which limit accessibility in resource-constrained healthcare settings. The complexity of acute pancreatitis management requires multidisciplinary approaches involving gastroenterologists, surgeons, and critical care specialists, creating challenges in standardized treatment protocols. Additionally, the lack of specific therapeutic drugs for pancreatitis treatment, with current management primarily focusing on supportive care, represents a significant market limitation. Nevertheless, substantial opportunities emerge from the growing aging population worldwide, as elderly individuals demonstrate higher susceptibility to pancreatic disorders. Increasing healthcare expenditure in developing nations, coupled with expanding medical insurance coverage, creates favorable market conditions. The integration of artificial intelligence in diagnostic imaging and the development of personalized medicine approaches present lucrative opportunities for market expansion and innovation in acute pancreatitis care.

Key Features of the Study

This report provides in-depth analysis of the global acute pancreatitis market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global acute pancreatitis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Boston Scientific, AbbVie, Cook Medical, Medtronic, Olympus Corporation, Fujifilm Healthcare, Pentax Medical, ConMed, Teleflex, Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Abbott Laboratories, ICU Medical, and ERBE Elektromedizin
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global acute pancreatitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acute pancreatitis market

Market Segmentation

Etiology Insights (Revenue, USD Bn, 2020 - 2032)
- Gallstone-induced
- Alcohol-induced
- Hypertriglyceridemia-induced
- Drug-induced
- Post-ERCP
- Autoimmune
- Genetic
- Idiopathic
Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
- Drug Based Therapy
- Analgesics
- Opioids
- Non-opioid analgesics
- Antiemetics
- Proton Pump Inhibitors (PPIs)
- Somatostatin and Analogues
- Intravenous Fluid Therapy Agents (Lactated Ringer's and Normal saline)
- Pancreatic Enzyme Supplements
- Device-Based Therapy
- Intravenous Fluids
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Nutritional Support
- Others (Antioxidant Treatment)
Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Parenteral
- Others
Patient Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatric
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Diagnostic Imaging Centers
- Research and Academic Institutes
Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Boston Scientific
- AbbVie
- Cook Medical
- Medtronic
- Olympus Corporation
- Fujifilm Healthcare
- Pentax Medical
- ConMed
- Teleflex
- Baxter International
- Braun Melsungen AG
- Fresenius Kabi
- Abbott Laboratories
- ICU Medical
- ERBE Elektromedizin

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Acute Pancreatitis Market, By Etiology
- Global Acute Pancreatitis Market, By Treatment Type
- Global Acute Pancreatitis Market, By Route of Administration
- Global Acute Pancreatitis Market, By Patient Group
- Global Acute Pancreatitis Market, By End User
- Global Acute Pancreatitis Market, By Distribution Channel
- Global Acute Pancreatitis Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Acute Pancreatitis Market, By Etiology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Gallstone-induced
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Alcohol-induced
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hypertriglyceridemia-induced
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Drug-induced
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Post-ERCP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Autoimmune
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Genetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Idiopathic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Acute Pancreatitis Market, By Treatment Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Based Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Analgesics
  - Opioids
  - Non-opioid analgesics
  - Antiemetics
  - Proton Pump Inhibitors (PPIs)
  - Somatostatin and Analogues
  - Intravenous Fluid Therapy Agents (Lactated Ringer's and Normal saline)
  - Pancreatic Enzyme Supplements
Device-Based Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  - Intravenous Fluids
  - Endoscopic Retrograde Cholangiopancreatography (ERCP)
Nutritional Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Antioxidant Treatment)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Acute Pancreatitis Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Acute Pancreatitis Market, By Patient Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Acute Pancreatitis Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Imaging Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Acute Pancreatitis Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Acute Pancreatitis Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Etiology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

Boston Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cook Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Olympus Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fujifilm Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pentax Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ConMed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teleflex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Kabi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ICU Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ERBE Elektromedizin
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies